Lumida
/OMDA
⌘K
Omada Health Inc

Omada Health Inc

OMDA
$19.66USD↓-8.56%-1.84 today

MARKET CAP

1.2B

P/E (TTM)

430.0x

FWD P/E

180.3x

DAY RANGE

$19 – $22

52W RANGE

$10
$27

AI Summary

Stalk
StalkMedium

OMDA has decisively broken near-term support on high volume, trading below its short-term EMAs in an extreme oversold context. While mean-reversion conditions permit a tactical long bias, the lack of reversal confirmation and sustained downward momentum argue for deferred execution. Focus on potential buy zones near the 17–18 area or after price stabilizes above the EMA cluster.

  • ↑Q2 2026 revenue reached $88M, up 43% YoY.
  • ↑Gross margin expanded 700bps to 73% year-over-year.
  • ↓Earnings yield negative, implying stretched valuation.
Full analysis →

Buying

3

institutions

Selling

8

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY2.22 M48.77 M+317.52 K+103.7%0.00%
MM

Millennium Management LLC

Q2 2026

BUY1.72 M37.84 M+620.06 K+172.7%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY1.21 M26.62 M+869.71 K+517.1%0.00%
PA

Perceptive Advisors LLC

Q2 2026

SELL786.33 K17.26 M+-786.33 K-12.7%0.26%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL598.00 K13.13 M+-308.21 K+15.2%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

SELL300.62 K6.51 M+-45.40 K+56.3%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL270.23 K5.93 M+-35.43 K+54.4%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL191.40 K4.20 M+-199.67 K-14.5%0.01%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL9.25 K202.97 K+-13.11 K-27.8%0.00%
RI

Rtw Investments, LP

Q2 2026

SELL0.000.00+-200.00 K-100.0%0.00%
MG

Man Group Plc

Q2 2026

SELL0.000.00+-16.02 K-100.0%0.00%